期刊文献+

肝细胞损伤的分子生物学机制 被引量:9

The molecular biological mechanisms of hepatocellular injury
原文传递
导出
摘要 随着医学研究的不断进展,我们对各种肝脏疾病的病因有了更加深入的了解,对疾病的治疗也渐渐从对症治疗转移到病因治疗,但是,在强调病因学治疗的同时,不应忽略对肝细胞的保护,因为肝细胞损伤是各型肝病共同的病理基础,是各种原因引起肝脏疾病的共同的表现。肝损伤的结果可致肝细胞死亡,甚至肝衰竭的发生。对于肝细胞死亡及肝细胞损伤机制的研究,有利于临床上防治各种肝损伤,建立多元化的治疗体系。
作者 谢青 赵钢德
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2008年第9期708-710,共3页 Chinese Journal of Hepatology
关键词 肝细胞 免疫性损伤 化学性损伤 发病机制 Hepatocytes Immune mediated injury Chemical injury Pathogenesis
  • 相关文献

参考文献1

二级参考文献24

  • 1Shiro Yokohama,Yoshihiko Tokusashi,Kimihide Nakamura,Yosui Tamaki,Satoshi Okamoto,Mituyoshi Okada,Kazunobu Aso,Takenao Hasegawa,Masaru Aoshima,Naoyuki Miyokawa,Masakazu Haneda,Masashi Yoneda.Inhibitory effect of angiotensinⅡreceptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis[J].World Journal of Gastroenterology,2006,12(2):322-326. 被引量:10
  • 2Jaskiewicz K.,Raczynska S.,Rzepko R.,Sledziński Z,纪泛扑.胃成形术治疗肥胖者的非酒精性脂肪性肝病[J].世界核心医学期刊文摘(胃肠病学分册),2006,2(6):4-5. 被引量:1
  • 3John B Dixon MBBS, PhD, FRACGP,Prithi S Bhathal MBBS, PhD, FRCPA,Paul E O’Brien MD, FRACS.Weight Loss and Non-alcoholic Fatty Liver Disease: Falls In Gamma-Glutamyl Transferase Concentrations are Associated with Histologic Improvement[J].Obesity Surgery.2006(10)
  • 4K. Jaskiewicz MD,S. Raczynska,R. Rzepko,Z. Sledziński.Nonalcoholic Fatty Liver Disease Treated by Gastroplasty[J].Digestive Diseases and Sciences.2006(1)
  • 5Charalabos Stratopoulos MD,Alexandros Papakonstantinou MD,Ioannis Terzis MD,Charis Spiliadi MD,George Dimitriades MD, PhD,Vasiliki Komesidou,Panagiota Kitsanta MD,Theodoros Argyrakos MD,Evagelos Hadjiyannakis MD, PhD.Changes in Liver Histology Accompanying Massive Weight Loss after Gastroplasty for Morbid Obesity[J].Obesity Surgery.2005(8)
  • 6Keishi Kanno MD,Susumu Tazuma MD,Tomoji Nishioka MD,Hideyuki Hyogo MD,Kazuaki Chayama MD.Angiotensin II Participates in Hepatic Inflammation and Fibrosis through MCP-1 Expression[J].Digestive Diseases and Sciences.2005(5)
  • 7Yao Hong Wei,Li Jun,Chen Ji Qiang.Effect of Losartan, an Angiotensin II Antagonist, on Hepatic Fibrosis Induced by CCl4 in Rats[J].Digestive Diseases and Sciences.2004(10)
  • 8Helena Cortez-Pinto,Amélia Baptista,Maria Ermelinda Camilo,Miguel Carneiro de Moura.Nonalcoholic Steatohepatitis—A Long-Term Follow-Up Study: Comparison with Alcoholic Hepatitis in Ambulatory and Hospitalized Patients[J].Digestive Diseases and Sciences.2003(10)
  • 9Shivakumar Chitturi MD,Jacob George MD.Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis[J].Current Gastroenterology Reports.2003(1)
  • 10Javier Crespo,Montserrat Rivero,Emilio Fábrega,Amalía Cayón,José Antonio Amado,Maria Teresa García-Unzeta,Fernando Pons-Romero.Plasma Leptin and TNF-α Levels in Chronic Hepatitis C Patients and Their Relationship to Hepatic Fibrosis[J].Digestive Diseases and Sciences.2002(7)

共引文献74

同被引文献78

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部